Skip to main content
SpringerLink
Log in

The present and future of radiolabelled antibodies in oncology

  • Review
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Britton KE, Granowska M. (1988). Radioimmimo-scintigraphy in tumour identification.Cancer surveys 6: 247–267

    Google Scholar 

  2. Britton KE, Granowska M, Mather SJ. (1991). Radiolabelled monoclonal antibodies in oncology I. Technical Aspects..Nucl Med Commun 12: 65–76

    Article  PubMed  CAS  Google Scholar 

  3. Buraggi GL, Turrin A, Cascinelli N, et al. (1984). Immunoscintigraphy with antimelanoma monoclonal antibodies. In: Donato L, Britton KE (eds) Proceedings of the European Symposium on Immuno-scintigraphy, Saariselka, Finland 1983. Monographs in Nuclear Medicine Vol I Immunoscintigraphy. Gordon & Breech, New York, pp 215–253.

    Google Scholar 

  4. Granowska M, Shepherd J, Britton KE, et al. (1984). Ovarian cancer: diagnosis using 123-I monoclonal antibody in comparison with surgical findings.Nucl Med Commun 5: 485–489

    Article  PubMed  CAS  Google Scholar 

  5. Granowska M, Britton KE, Shepherd J. (1984). The detection of ovarian cancer using 123-I monoclonal antibody.Radiobiol Radiother (Berlin) 25: 153–160

    CAS  Google Scholar 

  6. Epenetos AA, Britton KE, Mather S, Granowska M, et al. (1982). Targeting of Iodine-123 labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours.Lancet ii: 999–1005.

    Article  Google Scholar 

  7. Granowska M, Britton KE, Crowther M, Nimmon CC, Slevin ML, Shepherd J. (1986). Kinetic analysis with probability mapping in radioimmunoscintigraphy. In: Radiolabelled Monoclonal Antibodies for Imaging and Therapy 1988. Srivastava SC Ed, Plenum Press, New York. 152: 311–322

    Google Scholar 

  8. Granowska M, Nimmon CC, Britton KE, et al. (1988). Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radio-immunoscintigraphy.J Nucl Med 29: 599–607

    PubMed  CAS  Google Scholar 

  9. Rhodes BA, Burchiel SW. (1983). Radiolabelling of antibodies with technetium-99m. In Burchiel SW, Rhodes BA, eds. Radioimmunoimaging. Elsevier Science, New York, pp 207–222

    Google Scholar 

  10. Schwarz A, Steinstrasser A. (1987). A novel approach to Tc-99m-labelled monoclonal antibodies.J Nucl Med 28: 721

    Google Scholar 

  11. Burchell J, Gendler S, Taylor-Papadimitriou J, et al. (1987). Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin.Cancer, Res 47: 5476–5482

    CAS  Google Scholar 

  12. Burchell J, Taylor-Papadimitriou J, Boshell M, et al. (1989). A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes.Int J Cancer 44: 691–696

    Article  PubMed  CAS  Google Scholar 

  13. Siccardi AG, Buraggi GL, Callegaro L, et al. (1986). Multicentre study of immunoscintigraphy with radio-labelled monoclonal antibodies in patients with melanoma.Cancer Res 46: 4817–4822

    PubMed  CAS  Google Scholar 

  14. Bomanji J, Hungerford JL, Granowska M, Britton KE. (1987). Radioimmunoscintigraphy of ocular melanoma with 99m Tc labelled cutaneous melanoma antibodies.Br J Opthalmol 71: 651–658

    Article  CAS  Google Scholar 

  15. Bomanji J, Glaholm J, Hungerford JL, Mather SJ, Granowska M, Britton KE, Whitelocke R. (1990). Radioimmunoscintigraphy of Orbital Metastases from Ovarian Cancer.Clin Nucl Med 15: 825–827

    Article  PubMed  CAS  Google Scholar 

  16. Richman PI, Bodmer WF. (1987). Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization.Int J Cancer 39: 317–328

    Article  PubMed  CAS  Google Scholar 

  17. Granowska M, Jass JR, Britton KE, Northover JMA. (1989). A prospective study of the use of 111-Inlabelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake.Int J Colored Dis 4: 97–108

    Article  CAS  Google Scholar 

  18. Granowska M, Mather SJ, Britton KE. (1992). Technetium-99m-labelled antibodies for radio-immunoscintigraphy. In: Monoclonal antibodies, Epenetos AA, ed. Chapman & Hall, London.Chapter 38: 375–380

    Google Scholar 

  19. Coakham HB, Richardson RB, Davies AG, Bourne SP, Eckert H, Kemshead JT. (1988). Neoplastic meningitis from a pineal tumour treated by antibody guided irradiation via the intrathecal route.Brit J Neutosurg 2: 199–209

    Article  CAS  Google Scholar 

  20. Epenetos AA. (1992). Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.Nuc. Med Commun, 13: 218

    Article  Google Scholar 

  21. Riva P, Arista A. Sturiale C, Francheschi G, Spinelli A, Riva N, Casi M, Scassellati GA. (1992). Direct intratumour administration of radiolabelled monoclonal antibody: an effective therapeutic approach in glioblastomas.Eur J Nucl Med 19: 607

    Google Scholar 

  22. Britton KE. (1992). Radioisotope therapy of cancer —past, present and future: an overview. In: Monoclonal antibodies, Epenetos AA, ed. Chapman & Hall, London,Chapter 44: 429–439.

    Google Scholar 

  23. Britton KE. (1991). Overview of Radioimmunotherapy: A European Perspective.Antibody Immunoconj Radiopharm. 4: 133–150

    Google Scholar 

  24. Paganelli G, Magnani P, Zito F, Villa E, Sudati F, Lopalco L, Rossetti C, Malcovati M, Chiolerio F, Seccamani E, Siccardi AG, Fazio F. (1991). Threestep monoclonal antibody tumour targetting in carcinoembryonic antigen-positive patients.Cancer Res, 51: 5960–5966

    PubMed  CAS  Google Scholar 

  25. Foxwell BMJ, Band HA, Long J, Jeffrey WA, Snook D, Thorpe PE, Watson G, Parker PJ, Epenetos AA, Creighton AM. (1988). Conjugation of Monoclonal Antibodies to a Synthetic Peptide Substitute for Protein Kinase: A Method of Labelling Antibodies with 32-P.Br. J Cancer 57: 489–503.

    PubMed  CAS  Google Scholar 

  26. Winter G, Milstein C. (1991). Man made antibodies.Nature 349: 293–299

    Article  PubMed  CAS  Google Scholar 

  27. Bomanji J, Mather SJ, Ur E, Grossman A, Besser GM, Britton KE. (1992). Imaging somatostatin receptor positive neoplasms with 123-I-Tyr-3-octreotide and 111-In-DTPA-D-Phe-Octreotide somatostatin analogues.J Nucl Med, 33: 914

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St Bartholomews Hospital Medical College and St Marks Hospital, London, England

    Keith E Britton & Marie Granowska

Authors
  1. Keith E Britton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marie Granowska
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Britton, K.E., Granowska, M. The present and future of radiolabelled antibodies in oncology. Ann Nucl Med 7, 127–132 (1993). https://doi.org/10.1007/BF03164955

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164955

Keywords

Search

Navigation